The oncostatic action of melatonin in an ovarian carcinoma cell line

Journal of Pineal Research

Volumn 26, Issue 3, 1999, Pages 129-136

  Petranka, John ^a   Baldwin, William ^a   Biermann, Jennifer ^a   Jayadev, Supriya ^a   Barrett, J Carl ^a   Murphy, Elizabeth ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

Calcium; CGP52608; Flow cytometry

Indexed keywords

FURA 2; MELATONIN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CALCIUM MOBILIZATION; CARCINOMA CELL; CELL CYCLE G1 PHASE; CELL DEATH; CELL PROLIFERATION; DRUG EFFECT; FLOW CYTOMETRY; GROWTH INHIBITION; HUMAN; HUMAN CELL; MONOLAYER CULTURE; OVARY CARCINOMA; RECEPTOR BINDING;

EID: 0032964066     PISSN: 07423098     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-079X.1999.tb00574.x     Document Type: Article

References (30)

1. Becker-André, M., I. Wiesenberg, N. Schaeren-Wiemers, E. André, M. Missbach, J. Saurat, C. Carlberg (1994) Pineal gland hormone melatonin binds and activates an orphan of the nuclear receptor superfamily. J. Biol. Chem. 269:28531-28534.
2. Becker-André, M., I. Wiesenberg, N. Schaeren-Wiemers, E. André, M. Missbach, J. Saurat, C. Carlberg (1996) Additions and corrections to: Pineal gland hormone melatonin binds and activates an orphan of the nuclear receptor superfamily. J. Biol. Chem. 272:16707.
3. Benitez-King, G., F. Anton-Tay (1993) Calmodulin mediates melatonin cytoskeletal effects. Experientia 49:635-641.
4. Blask, D.E. (1993) Melatonin in Oncology. In: Melatonin Biosynthesis, Physiological Effects and Clinical Application, H.S. Yu, R.J. Reiter, eds. CRC Press, Inc., Boca Raton, FL, pp. 447-475.
5. Brzezinski, F. (1997) Melatonin in humans. N. Eng. J. Med. 336:186-195.
6. Burch J., J. Reif, M. Yost, T. Keefe, C. Pitrat (1998). Noctural excretion of a urinary melatonin metabolite in electrical utility workers. Scandinavian J. Work Environ. Health (in press).
7. Chen, L.D., B.Z. Leal, R.J. Reiter, M. Abe, E. Sewerynek, D. Melchiorri, M.L. Meltz, B. Poeggeler (1995) Melatonin's inhibitory effect on growth of ME-180 human cervical cancer cells is not related to intracellular glutathione levels. Cancer Lett. 91:153-159.
8. Cos, S., E.J. Sanchez-Barcelo (1995) Melatonin inhibition of MCF-7 human breast-cancer cells growth: Influence of cell proliferation rate. Cancer Lett. 93:207-212.
9. Cos, S., R. Verduga, C. Fernandez-Viadero, M. Megias, D. Crespo (1996) Effects of melatonin on the proliferation and differentiation of human neuroblastoma cells in culture. Neurosci. Lett. 216:113-116.
10. Dubocovich, M. (1995) Melatonin receptors: Are there multiple subtypes? Trends Physiol. Sci. 16:50-56.
11. Furuya, Y., K. Yamamoto, N. Kohno, Y. Ku., Y. Saito (1994) 5-Fluoracil attenuates an oncostatic effect of melatonin on estrogen-sensitive human breast cancer cells (MCF7). Cancer Lett. 81:95-98.
12. Geisenger, K.R., T.E. Kute, M.J. Pettanati, C.E. Dennard, Y. Collina, M.E. Berens (1989) Characterization of a human ovarian cell line with estrogen and progesterone receptors. Cancer 63:280-288.
13. Gilad, E., M. Laudon, H. Matzkin, E. Pick, M. Sofer, Z. Braf, N. Zisapel (1996) Functional melatonin receptors in human prostate epithelial cells. Endocrinology 137:1412-1417.
14. Graham, C., M. Cook, D. Riffle, M. Gerkovich, H. Cohen (1996) Nocturnal melatonin levels in human volunteers exposed to intermittent 60 Hz magnetic fields. Bioelec tromagnetics 17:263-273.
15. Greiner, E.F., J. Kirfel, H. Greschik, U. Dörflinger, P. Becker, A. Mercep, R. Schüle (1996) Functional analysis of retinoid Z receptor β, a brain-specific nuclear orphan receptor. Proc. Natl. Acad. Sci. USA 93:10105-10110.
16. Helton, R.A., W.A. Harrison, K. Kelley, M.A. Kane (1993) Melatonin interactions with cultured B16 melanoma cells. Melanoma Res. 3:403-413.
17. Hill, S.M., L.L. Spriggs, M.A. Simon, H. Muraoka, D.E. Blask (1992) The growth inhibitory activity of melatonin on human breast cancer cells is linked to the estrogen response system. Cancer Lett. 64:3249-3256.
18. Kato, M., K. Honma, T. Shigemitsu, Y. Shiga (1993) effects of exposure to a circularly polarized 50-hz magneticfield on plasma and pineal melatonin levels in rats. Bioelectromagnetics 14:97-106.
19. Konakchieva, R., S. Kyurkchiev, I. Kehayov, P. Taushanova, L. Kanchev (1995) Selective effect of methoxyindoles on the lymphocyte proliferation and melatonin binding to activated human lymphoid cells. J. Neuroimmunol. 63:125-132.
20. Lemus-Wilson, A., P.A. Kelly, D.E. Blask (1995) Melatonin blocks the stimulatory effects of prolactin on human breast cancer cell growth in culture. Br. J. Cancer 72:1435-1440.
21. Lerchl, A., K. Nonaka, K. Stokkan, R. Reiter (1990) Marked rapid alterations in nocturnal pineal serotonin metabolism in mice and rats exposed to weak intermittent magnetic fields. Biochem. Biophys. Res. Commun. 169:102-108.
22. Liburdy, R.P., T.R. Sloma, R. Sokolic, P. Yaswen (1993) ELF magnetic fields, breast cancer, and melatonin: 60 Hz fields block melatonin's oncostatic action on ER + breast cancer cell proliferation. J. Pineal Res. 14:89-97.
23. Missbach, M., B. Jagher, I. Sigg, S. Nayeri, C. Carlberg, I. Wiesenberg (1996) Thiazolidine diones, specific ligands of the nuclear receptor retinoid Z receptor/retinoid acid receptor-related orphan receptor α with potent antiarthritic activity. J. Biol. Chem. 271:13515-13522.
24. Persengiev, S.P., S. Kyurkchiev (1993) Selective effect of melatonin on the proliferation of lymphoid cells. Int. J. Biochem. 25:441-444.
25. Preston, G., J. Barrett, J. Biermann, E. Murphy (1997) Effects of alterations in calcium homeostasis on apoptosis during neoplastic progression. Cancer Res. 57:537-542.
26. Reiter, R.J., D. Melchiorri, E. Sewerynek, B. Poeggeler, L. Barlow-Walden, J. Chuang, G.G. Ortiz, D. Acuna-Castroviejo (1995) A review of the evidence supporting melatonin's role as an antioxidant. J. Pineal Res. 18:1-11.
27. Slominski, A., D. Pruski (1993) Melatonin inhibits proliferation and melanogenesis in rodent melanoma cells. Exp. Cell Res. 206:189-194.
28. Stevens, R., S. Davis (1996) The melatonin hypothesis: Electric power and breast cancer. Environ. Health Perspect. 104(Suppl 1):135-140.
29. Wiesenberg, I., M. Missbach, J. Kahlen, M. Schrader, C. Carlberg (1995) Transcriptional activation of the nuclear receptor RZR by the pineal gland hormone melatonin and identification of CGP52608 as a synthetic ligand. Nucl. Acid. Res. 23:327-333.
30. Ying, S.W., L.P. Niles, C. Crocker (1993) Human malignant melanoma cells express high-affinity receptors for melatonin: Antiproliferative effects of melatonin and 6-chloromelatonin. Eur. J. Pharmacol. 246:89-96.